Mechanistic studies indicate that GSDME-mediated pyroptosis can promote tumor antigen presentation and enhance T cell infiltration by releasing inflammatory factors such as IL-1β and IL-18, thereby improving the tumor immune microenvironment. This evidence concerns the gene IL1B and neoplasm.